Related Experiment Video

Updated: Aug 4, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

[Short Communication: Rotation-viscosimetric determinations of the effect of ipratropiumbromide on bronchial

E Stresemann

    Arzneimittel-Forschung
    |January 1, 1976
    PubMed

    In a double blind cross-over study using randomized selection the effects of 3 x 2 puffs (8r)-3alpha-hydroxy-8-isopropyl-1aH, 5aH-tropaniumbromide-(+/-)-tropate (ipratropiumbromide, Sch 1000, Atrovent) (0.02 mg per puff) from a metered dose inhaler were compared with placebo in 25 patients. The parameters studied were the amount of morning sputum, sputum viscosity as measured by rotational viscosimetry and total airways resistance (Rt) measured by whole-body plethysmography during 2 successive treatment periods, each of 5 days, sepraated by 2 rest days. The patient material consisted of 16 males and 9 females, ages 21-66 (mean 47), 15 of whom had bronchial asthma and 10 chronic bronchitis. Both groups received multiple supplementary viscosity or volume but the Rt was significantly decreased by 11-15% only after ipratropiumbromide when measured 10 min after inhalation. Non-characteristic side effects occurred with equal frequency in the ipratropiumbromide and placebo groups. Therefore ipratropiumbromide has a clear bronchospasmolytic action without secretion-inhibiting properties if used in therapeutic dosage.

    More Related Videos

    Conducting Respiratory Oscillometry in an Outpatient Setting14:49

    Conducting Respiratory Oscillometry in an Outpatient Setting

    Published on: April 8, 2022

    Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer08:47

    Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

    Published on: April 21, 2022

    Related Concept Videos

    Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

    Direct-Acting Cholinergic Agonists: Therapeutic Uses

    Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
    Cholinergic Antagonists: Pharmacokinetics01:24

    Cholinergic Antagonists: Pharmacokinetics

    Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.
    Cholinergic Antagonists: Therapeutic Uses01:26

    Cholinergic Antagonists: Therapeutic Uses

    Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
    Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
    Inhaled Medications01:23

    Inhaled Medications

    Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...